MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,366,154 | -2.8% | 65,490 | 0.0% | 0.09% | 0.0% |
| Q1 2023 | $2,434,918 | -17.9% | 65,490 | 0.0% | 0.09% | -17.0% |
| Q4 2022 | $2,967,352 | -65.3% | 65,490 | -46.5% | 0.11% | -68.0% |
| Q3 2022 | $8,548,000 | +52.0% | 122,390 | +46.1% | 0.35% | +58.4% |
| Q2 2022 | $5,624,000 | -18.4% | 83,784 | 0.0% | 0.22% | -8.7% |
| Q1 2022 | $6,889,000 | -43.9% | 83,784 | 0.0% | 0.24% | -38.7% |
| Q4 2021 | $12,290,000 | -17.1% | 83,784 | 0.0% | 0.40% | -17.2% |
| Q3 2021 | $14,822,000 | +9.5% | 83,784 | 0.0% | 0.48% | +8.4% |
| Q2 2021 | $13,534,000 | -5.7% | 83,784 | 0.0% | 0.44% | -10.9% |
| Q1 2021 | $14,352,000 | -22.0% | 83,784 | 0.0% | 0.49% | -23.6% |
| Q4 2020 | $18,402,000 | +40.7% | 83,784 | +6.3% | 0.65% | +32.0% |
| Q3 2020 | $13,082,000 | +45.4% | 78,784 | 0.0% | 0.49% | +43.3% |
| Q2 2020 | $8,995,000 | +48.5% | 78,784 | 0.0% | 0.34% | +24.8% |
| Q1 2020 | $6,056,000 | -33.7% | 78,784 | +11.2% | 0.27% | -20.6% |
| Q4 2019 | $9,133,000 | +47.1% | 70,873 | -11.1% | 0.34% | +27.3% |
| Q3 2019 | $6,208,000 | +343.4% | 79,687 | +486.4% | 0.27% | +375.4% |
| Q2 2019 | $1,400,000 | +40.6% | 13,590 | 0.0% | 0.06% | +42.5% |
| Q1 2019 | $996,000 | +72.9% | 13,590 | 0.0% | 0.04% | +60.0% |
| Q4 2018 | $576,000 | -10.0% | 13,590 | 0.0% | 0.02% | +8.7% |
| Q3 2018 | $640,000 | – | 13,590 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |